Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cencora, Inc. Common Stock (NY:COR)

292.87 -1.51 (-0.51%)
Official Closing Price Updated: 7:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Where Cencora Stands With Analysts
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
3 Large-Cap Stocks to Keep an Eye On
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for... 
Via StockStory
Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release
From Cencora
Via Business Wire
3 Big Reasons to Love Cencora (COR)
Since July 2020, the S&P 500 has delivered a total return of 97.8%. But one standout stock has doubled the market - over the past five years, Cencora has surged 196% to $296 per share. Its momentum... 
Via StockStory
Topics Stocks Supply Chain
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Assessing Cencora: Insights From 6 Financial Analysts
Via Benzinga
Health Insurance Providers Stocks Q1 Recap: Benchmarking Cencora (NYSE:COR)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how health insurance providers stocks fared in Q1, starting with... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
6 Analysts Have This To Say About Cencora
Via Benzinga
2 Surging Stocks to Research Further and 1 to Be Wary Of
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today
Via Benzinga
What's Driving the Market Sentiment Around Cencora?
Via Benzinga
3 S&P 500 Stocks to Own for Decades
The S&P 500 (^GSPC) is packed with companies that have built dominant market positions, making it a core index for investors. A select few continue to innovate and expand, setting themselves up for... 
Via StockStory
Topics Stocks
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Top S&P500 movers in Thursday's session
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session. 
Via Chartmill
COR Q1 Earnings Call: Specialty Expansion, RCA Impact, and International Softness Highlight Results
Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 10.3% year on year to $75.45 billion. Its non-GAAP profit of $4.42 per share was 7.9% above... 
Via StockStory
1 Safe-and-Steady Stock to Target This Week and 2 to Think Twice About
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
3 Market-Beating Stocks with Promising Prospects
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends... 
Via StockStory
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Cencora Elects Lori J. Ryerkerk to Its Board of Directors
From Cencora
Via Business Wire
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
Top S&P500 movers in Monday's pre-market session
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. 
Via Chartmill
Top S&P500 movers in Thursday's session
Let's delve into the developments on the US markets one hour before the close of the markets on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Discover which S&P500 stocks are making waves on Thursday.
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Thursday's session: gap up and gap down stock in the S&P500 index
Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
Top S&P500 movers in Wednesday's session
Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings
Cencora raised its 2025 earnings forecast after a strong Q2 driven by U.S. drug sales, though total revenue of $75.5 billion slightly missed expectations. 
Via Benzinga
Cencora Reports Upbeat Q2 Earnings, Revises Fiscal Year 2025 Guidance: Retail’s Pleased
The company raised its fiscal year 2025 adjusted EPS guidance to $15.70 to $15.95 compared to a previous range of $15.30 to $15.60. 
Via Stocktwits
Cencora’s (NYSE:COR) Q1 Earnings Results: Revenue In Line With Expectations
Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 10.3% year on year to $75.45 billion. Its non-GAAP profit of $4.42 per share was 7.9% above... 
Via StockStory
Topics Economy
Cencora Reports Fiscal 2025 Second Quarter Results
From Cencora
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.